FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

2728611000001102: Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) 60 tablet 4 x 15 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1886601000001113 Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) 60 tablet 4 x 15 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1886621000001118 Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) 60 tablet 4 x 15 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) 60 tablet 4 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) 60 tablet 4 x 15 tablets Is a Ranitidine 150mg effervescent tablets 60 tablet true Inferred relationship Existential restriction modifier
Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) 60 tablet 4 x 15 tablets Is pack of Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) false Inferred relationship Existential restriction modifier
Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) 60 tablet 4 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free false Inferred relationship Existential restriction modifier
Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) 60 tablet 4 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) 60 tablet 4 x 15 tablets VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) 60 tablet 4 x 15 tablets Has active ingredient Ranitidine hydrochloride false Inferred relationship Existential restriction modifier
Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) 60 tablet 4 x 15 tablets Has active ingredient Ranitidine false Inferred relationship Existential restriction modifier
Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) 60 tablet 4 x 15 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) 60 tablet 4 x 15 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) 60 tablet 4 x 15 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) 60 tablet 4 x 15 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) 60 tablet 4 x 15 tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) 60 tablet 4 x 15 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) 60 tablet 4 x 15 tablets Has AMP Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) 60 tablet 4 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) 60 tablet 4 x 15 tablets Has specific active ingredient Ranitidine hydrochloride true Inferred relationship Existential restriction modifier
Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) 60 tablet 4 x 15 tablets Has dispensed dose form Effervescent tablet false Inferred relationship Existential restriction modifier
Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) 60 tablet 4 x 15 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) 60 tablet 4 x 15 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) 60 tablet 4 x 15 tablets Has basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Ranitidine 150mg effervescent tablets (Kent Pharma (UK) Ltd) 60 tablet 4 x 15 tablets Has dispensed dose form Conventional release effervescent oral tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start